FNY Managed Accounts’s Assembly Biosciences ASMB Stock Holding History

FNY Managed Accounts’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-317	Closed	-$46.2K	–	735
2016 Q4	$46.2K	Buy	+317	New	+$47.1K	0.31%	22

Other funds holding ASMB

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FNY Managed Accounts's ASMB Position: Q1 2017 in Review

FNY Managed Accounts sold out of Assembly Biosciences (ASMB) in Q1 2017, closing a stake of 317 shares — an estimated $46.2K sold.

FNY Managed Accounts first reported a position in ASMB in Q4 2016 and held it in 1 quarter. The position peaked at $46.2K in Q4 2016. 49 funds tracked by Wall St. Rank hold ASMB as of Q1 2017.

FNY Managed Accounts reported no remaining Assembly Biosciences position as of Q1 2017 after selling out during the quarter.
FNY Managed Accounts sold 317 Assembly Biosciences shares in Q1 2017, an estimated $46.2K.
FNY Managed Accounts first reported a position in Assembly Biosciences in Q4 2016 and held it in 1 quarter.
FNY Managed Accounts's Assembly Biosciences position peaked at $46.2K in Q4 2016.
49 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2017.

Based on FNY Managed Accounts's 13F filing for Q1 2017, filed 15 May 2017.